1. Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19(2):154–7.
2. Turner L. Direct-to-consumer marketing of stem cell interventions by Canadian businesses. Regen Med. 2018;13(06):643–58.
3. Food and Drug Administration. FDA warns about stem cell therapies; 2017.
https://www.fda.gov/forconsumers/consumerupdates/ucm286155.htm
. Accessed 18 Dec 2018.
4. Crowe K. Unapproved stem cell therapies on the market in Canada. CBC News. 2017.
https://www.cbcca/news/health/stem-cell-private-clinic-health-canada-osteoarthritis-14401391
Accessed 19 Dec 2018.
5. Government of Canada. Guidance document: preparation of clinical trial applications for use of cell therapy products in humans; 2015.
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/guidance-document-preparation-clinical-trial-applications-use-cell-therapy-products-humans.html
. Accessed 19 Dec 2018.